ID

21886

Descrição

VTD Followed By MPT Maintenance As a First Line Treatment For The Patients With MM Who Are Non-Transplant Candidates; ODM derived from: https://clinicaltrials.gov/show/NCT00320476

Link

https://clinicaltrials.gov/show/NCT00320476

Palavras-chave

Versões (1)
  1. 06/05/2017 06/05/2017 -
Transferido a

6 de maio de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Multiple Myeloma NCT00320476

Inglês

Eligibility Multiple Myeloma NCT00320476

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
newly diagnosed patients with overt multiple myeloma who are not candidates for hdt/sct because of old age (> 65) or presence of comorbid conditions likely to have a negative impact on tolerability of hdt/sct. sponsors review this conditions and approval is required.
Descrição

Multiple Myeloma | Therapeutic procedure High dose Absent | Hemopoietic stem cell transplant Absent | Age | Comorbidity

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0026764
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0444956
UMLS CUI [2,3]
C0332197
UMLS CUI [3,1]
C0472699
UMLS CUI [3,2]
C0332197
UMLS CUI [4]
C0001779
UMLS CUI [5]
C0009488
presence of measurable disease : serum m-protein > 1g/dl or urine m- protein > 400mg/day
Descrição

Measurable Disease | M Protein Serum | M Protein Urine

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2,1]
C0700271
UMLS CUI [2,2]
C0229671
UMLS CUI [3,1]
C0700271
UMLS CUI [3,2]
C0042036
performance status £ ecog 2
Descrição

ECOG performance status

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1520224
expected survival ³ 6 months
Descrição

Life Expectancy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0023671
pretreatment clinical laboratory values meeting the following criteria within 14 days before enrollment platelet ≥ 100 x 109/l hemoglobin ≥ 8 g/dl (≥ 4.96 mol/l) prior rbc transfusion or recombinant human erythropoietin use is allowed) absolute neutrophil count (anc) ≥ 1.0 x 109/l aspartate aminotransferase (ast) ≤ 2.5 times the upper limit of normal alanine aminotransferase (alt) ≤ 2.5 times the upper limit of normal total bilirubin ≤ 1.5 times the upper limit of normal serum creatinine ≤
Descrição

Laboratory Results Pretreatment | Platelet Count measurement | Hemoglobin measurement | Red Blood Cell Transfusion | Recombinant Erythropoietin | Absolute neutrophil count | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Serum total bilirubin measurement | Creatinine measurement, serum

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1254595
UMLS CUI [1,2]
C3539075
UMLS CUI [2]
C0032181
UMLS CUI [3]
C0518015
UMLS CUI [4]
C0086252
UMLS CUI [5]
C0376541
UMLS CUI [6]
C0948762
UMLS CUI [7]
C0201899
UMLS CUI [8]
C0201836
UMLS CUI [9]
C1278039
UMLS CUI [10]
C0201976
3mg/dl corrected serum calcium <14 mg/dl (<3.5 mmol/l)
Descrição

Corrected serum calcium measurement

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0455288
subjects (or their legally acceptable representatives) must have signed an informed consent document indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study.
Descrição

Informed Consent | Informed Consent Patient Representatives

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C0030701
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
smoldering or indolent myeloma
Descrição

Smoldering myeloma | Indolent Myeloma

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1531608
UMLS CUI [2]
C1334169
history of allergic reaction attributable to compounds containing boron or mannitol
Descrição

Allergic Reaction Boron Compounds | Allergic Reaction Mannitol Compound

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1527304
UMLS CUI [1,2]
C0006031
UMLS CUI [2,1]
C1527304
UMLS CUI [2,2]
C0024730
UMLS CUI [2,3]
C1706082
known hypersensitivity to thalidomide or dexamethasone
Descrição

Hypersensitivity Thalidomide | Dexamethasone allergy

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0039736
UMLS CUI [2]
C0571611
peripheral neuropathy or neuropathic pain grade 2 or higher as defined by nci ctcae version 3
Descrição

Peripheral Neuropathy CTCAE Grades | Peripheral neuropathic pain CTCAE Grades

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0031117
UMLS CUI [1,2]
C1516728
UMLS CUI [2,1]
C0458960
UMLS CUI [2,2]
C1516728
uncontrolled or severe cardiovascular disease, including mi within 6 months of enrolment, new york heart association (nyha) class iii or iv heart failure, uncontrolled angina, clinically significant pericardial disease, or cardiac amyloidosis, cardiac ejection fraction <0.5 : severe conduction disorder : hypotension (sitting systolic bp ≤ 100 mmhg and/or sitting diastolic bp ≤ 60 mmhg
Descrição

Cardiovascular Disease Uncontrolled | Cardiovascular Disease Severe | Myocardial Infarction | Heart failure New York Heart Association Classification | Angina control - poor | Disorder of pericardium | Cardiac amyloidosis | Cardiac ejection fraction | Conduction disorder of the heart Severe | Hypotension | Sitting systolic blood pressure | Sitting diastolic blood pressure

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0007222
UMLS CUI [2,2]
C0205082
UMLS CUI [3]
C0027051
UMLS CUI [4,1]
C0018801
UMLS CUI [4,2]
C1275491
UMLS CUI [5]
C0421196
UMLS CUI [6]
C0265122
UMLS CUI [7]
C0268407
UMLS CUI [8]
C0232174
UMLS CUI [9,1]
C0264886
UMLS CUI [9,2]
C0205082
UMLS CUI [10]
C0020649
UMLS CUI [11]
C1319893
UMLS CUI [12]
C1319894
sepsis
Descrição

Sepsis

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0243026
pregnancy or breastfeeding
Descrição

Pregnancy | Breast Feeding

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
uncontrolled diabetes mellitus
Descrição

Diabetic - poor control

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0421258
recurrent dvt or pulmonary embolism
Descrição

Recurrent deep vein thrombosis | Pulmonary Embolism

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1735901
UMLS CUI [2]
C0034065
active ulcers detected by gastroscopy
Descrição

Ulcer Endoscopy of stomach

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0041582
UMLS CUI [1,2]
C0017195
serious medical or psychiatric illness likely to interfere with participation in this clinical study.
Descrição

Illness Serious Interferes with Study Subject Participation Status | Mental disorder Serious Interferes with Study Subject Participation Status

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0521102
UMLS CUI [1,4]
C2348568
UMLS CUI [2,1]
C0004936
UMLS CUI [2,2]
C0205404
UMLS CUI [2,3]
C0521102
UMLS CUI [2,4]
C2348568
receipt of extensive radiation therapy within 4 weeks
Descrição

Extensive Radiation

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1517030
Voltar ao início da página

Similar models

Eligibility Multiple Myeloma NCT00320476

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Multiple Myeloma | Therapeutic procedure High dose Absent | Hemopoietic stem cell transplant Absent | Age | Comorbidity
Item
newly diagnosed patients with overt multiple myeloma who are not candidates for hdt/sct because of old age (> 65) or presence of comorbid conditions likely to have a negative impact on tolerability of hdt/sct. sponsors review this conditions and approval is required.
boolean
C0026764 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0444956 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0472699 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0001779 (UMLS CUI [4])
C0009488 (UMLS CUI [5])
Measurable Disease | M Protein Serum | M Protein Urine
Item
presence of measurable disease : serum m-protein > 1g/dl or urine m- protein > 400mg/day
boolean
C1513041 (UMLS CUI [1])
C0700271 (UMLS CUI [2,1])
C0229671 (UMLS CUI [2,2])
C0700271 (UMLS CUI [3,1])
C0042036 (UMLS CUI [3,2])
ECOG performance status
Item
performance status £ ecog 2
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
expected survival ³ 6 months
boolean
C0023671 (UMLS CUI [1])
Laboratory Results Pretreatment | Platelet Count measurement | Hemoglobin measurement | Red Blood Cell Transfusion | Recombinant Erythropoietin | Absolute neutrophil count | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Serum total bilirubin measurement | Creatinine measurement, serum
Item
pretreatment clinical laboratory values meeting the following criteria within 14 days before enrollment platelet ≥ 100 x 109/l hemoglobin ≥ 8 g/dl (≥ 4.96 mol/l) prior rbc transfusion or recombinant human erythropoietin use is allowed) absolute neutrophil count (anc) ≥ 1.0 x 109/l aspartate aminotransferase (ast) ≤ 2.5 times the upper limit of normal alanine aminotransferase (alt) ≤ 2.5 times the upper limit of normal total bilirubin ≤ 1.5 times the upper limit of normal serum creatinine ≤
boolean
C1254595 (UMLS CUI [1,1])
C3539075 (UMLS CUI [1,2])
C0032181 (UMLS CUI [2])
C0518015 (UMLS CUI [3])
C0086252 (UMLS CUI [4])
C0376541 (UMLS CUI [5])
C0948762 (UMLS CUI [6])
C0201899 (UMLS CUI [7])
C0201836 (UMLS CUI [8])
C1278039 (UMLS CUI [9])
C0201976 (UMLS CUI [10])
Corrected serum calcium measurement
Item
3mg/dl corrected serum calcium <14 mg/dl (<3.5 mmol/l)
boolean
C0455288 (UMLS CUI [1])
Informed Consent | Informed Consent Patient Representatives
Item
subjects (or their legally acceptable representatives) must have signed an informed consent document indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study.
boolean
C0021430 (UMLS CUI [1])
C0021430 (UMLS CUI [2,1])
C0030701 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Smoldering myeloma | Indolent Myeloma
Item
smoldering or indolent myeloma
boolean
C1531608 (UMLS CUI [1])
C1334169 (UMLS CUI [2])
Allergic Reaction Boron Compounds | Allergic Reaction Mannitol Compound
Item
history of allergic reaction attributable to compounds containing boron or mannitol
boolean
C1527304 (UMLS CUI [1,1])
C0006031 (UMLS CUI [1,2])
C1527304 (UMLS CUI [2,1])
C0024730 (UMLS CUI [2,2])
C1706082 (UMLS CUI [2,3])
Hypersensitivity Thalidomide | Dexamethasone allergy
Item
known hypersensitivity to thalidomide or dexamethasone
boolean
C0020517 (UMLS CUI [1,1])
C0039736 (UMLS CUI [1,2])
C0571611 (UMLS CUI [2])
Peripheral Neuropathy CTCAE Grades | Peripheral neuropathic pain CTCAE Grades
Item
peripheral neuropathy or neuropathic pain grade 2 or higher as defined by nci ctcae version 3
boolean
C0031117 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
C0458960 (UMLS CUI [2,1])
C1516728 (UMLS CUI [2,2])
Cardiovascular Disease Uncontrolled | Cardiovascular Disease Severe | Myocardial Infarction | Heart failure New York Heart Association Classification | Angina control - poor | Disorder of pericardium | Cardiac amyloidosis | Cardiac ejection fraction | Conduction disorder of the heart Severe | Hypotension | Sitting systolic blood pressure | Sitting diastolic blood pressure
Item
uncontrolled or severe cardiovascular disease, including mi within 6 months of enrolment, new york heart association (nyha) class iii or iv heart failure, uncontrolled angina, clinically significant pericardial disease, or cardiac amyloidosis, cardiac ejection fraction <0.5 : severe conduction disorder : hypotension (sitting systolic bp ≤ 100 mmhg and/or sitting diastolic bp ≤ 60 mmhg
boolean
C0007222 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0007222 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0027051 (UMLS CUI [3])
C0018801 (UMLS CUI [4,1])
C1275491 (UMLS CUI [4,2])
C0421196 (UMLS CUI [5])
C0265122 (UMLS CUI [6])
C0268407 (UMLS CUI [7])
C0232174 (UMLS CUI [8])
C0264886 (UMLS CUI [9,1])
C0205082 (UMLS CUI [9,2])
C0020649 (UMLS CUI [10])
C1319893 (UMLS CUI [11])
C1319894 (UMLS CUI [12])
Sepsis
Item
sepsis
boolean
C0243026 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnancy or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Diabetic - poor control
Item
uncontrolled diabetes mellitus
boolean
C0421258 (UMLS CUI [1])
Recurrent deep vein thrombosis | Pulmonary Embolism
Item
recurrent dvt or pulmonary embolism
boolean
C1735901 (UMLS CUI [1])
C0034065 (UMLS CUI [2])
Ulcer Endoscopy of stomach
Item
active ulcers detected by gastroscopy
boolean
C0041582 (UMLS CUI [1,1])
C0017195 (UMLS CUI [1,2])
Illness Serious Interferes with Study Subject Participation Status | Mental disorder Serious Interferes with Study Subject Participation Status
Item
serious medical or psychiatric illness likely to interfere with participation in this clinical study.
boolean
C0221423 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C2348568 (UMLS CUI [1,4])
C0004936 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0521102 (UMLS CUI [2,3])
C2348568 (UMLS CUI [2,4])
Extensive Radiation
Item
receipt of extensive radiation therapy within 4 weeks
boolean
C1517030 (UMLS CUI [1])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial